One Bio Azione

One Bio Conversione FCF

Il Tasso di Conversione FCF (FCF/EBITDA) di One Bio (ONBI) al 13 ago 2026 è -20,05 %.

Conversione FCF

-20,05 %

Ultimo aggiornamento:

Tasso di Conversione FCF (FCF/EBITDA) di One Bio ammonta a 2026 -20,05 % . Tasso di Conversione FCF (FCF/EBITDA) di One Bio ammontava a 2025 - . Diminuisce del % inferiore rispetto all'anno precedente.
Access this data via the Eulerpool API

One Bio Analisi delle Azioni

Cosa fa One Bio? One Bio Corp is a US-based company specializing in biotechnological research, development, and production of biological and similar products. The company is headquartered in Miami, Florida and was founded in 1978. The history of One Bio Corp began with the development of enzymatic cleaning agents for the carpet industry in the late 1970s. Over the years, the company has become a key player in the field of biotechnology and the life sciences through acquisitions, mergers, and partnerships. Through its research and development efforts, One Bio Corp has been able to develop a wide range of products and services for various industries such as pharmaceuticals, cosmetics, food, animal feed, agriculture, and environmental technology. One Bio Corp offers a wide range of products for various applications. These include DNA test kits for pets and horses, dietary supplements for humans and animals, as well as pesticides and fungicides for agriculture. Additionally, One Bio Corp also provides diagnostic and testing services for infectious diseases and other health-related tests. One Bio Corp has several divisions focusing on different aspects of biotechnology and biological research. This includes the Life Sciences division, which focuses on the development of dietary supplements, diagnostic tests, and cosmetic products. The Agricultural Solutions division offers pesticides, fungicides, and other products for agriculture. The Veterinary Diagnostics division provides DNA test kits for pets and horses. Lastly, the Environmental Solutions division specializes in the development of products and services to improve environmental quality. One Bio Corp's business model is focused on long-term growth and success. The company concentrates on developing products and services that meet the needs of customers and end consumers. One Bio Corp pursues a strong marketing and distribution strategy to successfully market and promote its products and services. Additionally, the company collaborates closely with partners and research institutions to develop innovative technologies and products. Overall, One Bio Corp is an innovative biotechnological company that focuses on developing products and services tailored to the needs of customers and end consumers. The company follows a clear business strategy and relies on innovative research and development to achieve long-term growth and success. One Bio è una delle aziende più popolari su Eulerpool.com.

Domande frequenti su One Bio azioni

Tasso di Conversione FCF (FCF/EBITDA) di One Bio è -20,05 % nel 2026.

Su Eulerpool è possibile consultare lo sviluppo storico completo del One Bio di Tasso di Conversione FCF (FCF/EBITDA) dal 2006, con valori annuali, grafici e analisi dettagliate.

La conversione FCF misura l'efficacia con cui l'EBITDA si converte in flusso di cassa libero. Una conversione più elevata indica un'efficiente allocazione di capitale e bassi costi di manutenzione.

Un 'buono' varia a seconda del settore e della fase di sviluppo dell'azienda. Su Eulerpool puoi confrontare One Bio di Tasso di Conversione FCF (FCF/EBITDA) con i competitor del settore e la media industriale per valutare se è attraente.

Per valutare di Tasso di Conversione FCF (FCF/EBITDA), è essenziale confrontarlo con i competitor nello stesso settore e industria. Su Eulerpool puoi trovare confronti diretti con l'industria per Tasso di Conversione FCF (FCF/EBITDA).

Access this data via the Eulerpool API

Flussi di cassa — One Bio

Tutte le Metriche Finanziarie — One Bio